API Linzagolix Powder 99% prity for Treatment research on uterine endometriosis and adenomyosis
935283-04-8
Pharmaceutical Grade
99%
qingdao
jf
g
2025-12-12
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceLinzagolix is an orally bioavailable gonadotropin-releasing hormone (GnRH or LHRH) receptor antagonist, with potential hormone production inhibitory activity. Upon oral administration of linzagolix, this agent competes with GnRH for receptor binding and inhibits GnRH receptor signaling in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with hormonally dependent disease states such as hormone-dependent prostate cancer. In women, this prevents the production of estrogen by the ovaries and may relieve symptoms from sex-hormone dependent diseases, such as pain associated with endometriosis, heavy menstrual bleeding or uterine fibroids.Basic Info
-
Product Name:
3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyloxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid
Other Name:5-Carboxy-3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyloxy)-4-methoxyphenyl]thieno[3,4-d]pyrimidine-2,4(1H,3H)-dione;
CAS No.:935283-04-8
Molecular Formula:C22H15F3N2O7S
InChIKeys:BMAAMIIYNNPHAB-UHFFFAOYSA-N
Molecular Weight:508.4
Exact Mass:508.055
UNII:7CDW97HUEX
NCI Thesaurus Code:C148479
Categories:
Characteristics-
PSA:
148.09
XLogP3:3.4522
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Location:
Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
51-100
-
Year of Establishment:
2012
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Factory Supply High Purity Dsip 5mg 10mg Delta-Sleep Peptide CAS 62568-57-4
Pharmaceutical Grade / 99%
$22-23/UNIT FOB
-
-
-
-
Hot Selling Epithalon Peptide CAS:307297-39-8 Beauty Care Lyophilized powder
Pharmaceutical Grade / 99%
$22-23/UNIT FOB
-
-
-
-
99% Purity Weight Loss Peptide CAS 87805-34-3 GLP-1 Tirz Reta
Pharmaceutical Grade / 99%
$22-23/G FOB
-
-
-
-
Bulk Hydroxyapatite Powder Cosmetic Manufacturer
Cosmetics Grade / 99%
$100-120/UNIT EXW
-
-
-
-
Cibinetide, ARA-290, ARA290, PH-BSP/neuroprotection research, anti-inflammatory research, tissue repair research/diabetic peripheral neuropathy resear
Pharmaceutical Grade / 99%
$100-130/G FOB
-
-
-
-
High Purity Raw Material Supplier KY19382 Powder CAS 2226664-93-1
Pharmaceutical Grade / 99%
-